The abstract is read at the publisher; the summary is JClub's.
CGP20712A and NDD825 achieve hβ1AR selectivity by enabling H4–H5 cleft opening and faster association in turkey tβ1AR, unlike hβ2AR.
- Why it matters: Subtype-selective β1 antagonists are limited by conserved orthosteric binding sites, so the molecular basis for discrimination between hβ1AR and hβ2AR remains incomplete.
- What they did: They solved three cryo-EM structures of each antagonist bound to inactive turkey tβ1AR with Nb60.5, then used mutagenesis, receptor chimeras, kinetic assays, and MD simulations to test entry and dissociation.
- The result: All three ligands associated more rapidly with hβ1AR than hβ2AR, while dissociation depended on ligand; chimeras implicated the hβ1AR extracellular vestibule and MD showed H4–H5 cleft opening is feasible in hβ1AR but inaccessible in hβ2AR.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.